Amicin may be available in the countries listed below.
Ingredient matches for Amicin
Amikacin
Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amicin in the following countries:
- India
International Drug Name Search
Monday, October 25, 2010
Thursday, October 21, 2010
Peroxyderm
Peroxyderm may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ingredient matches for Peroxyderm
Benzoyl Peroxide
Benzoyl Peroxide is reported as an ingredient of Peroxyderm in the following countries:
- Austria
- Germany
- Netherlands
- Switzerland
International Drug Name Search
Thursday, October 14, 2010
Tamsulosin Hydrochloride Kiron
Tamsulosin Hydrochloride Kiron may be available in the countries listed below.
Ingredient matches for Tamsulosin Hydrochloride Kiron
Tamsulosin
Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosin Hydrochloride Kiron in the following countries:
- Latvia
International Drug Name Search
Monday, October 4, 2010
Flutonin 10 / 20
Flutonin 10/20 may be available in the countries listed below.
Ingredient matches for Flutonin 10/20
Fluoxetine
Fluoxetine is reported as an ingredient of Flutonin 10/20 in the following countries:
- Vietnam
International Drug Name Search
Friday, September 3, 2010
Busulfex
Busulfex is a brand name of busulfan, approved by the FDA in the following formulation(s):
BUSULFEX (busulfan - injectable; injection)
Manufacturer: OTSUKA PHARM
Approval date: February 4, 1999
Strength(s): 6MG/ML [RLD]
Has a generic version of Busulfex been approved?
No. There is currently no therapeutically equivalent version of Busulfex available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Busulfex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Parenteral busulfan for treatment of malignant disease
Patent 5,430,057
Issued: July 4, 1995
Inventor(s): Andersson; Borje S. & Bhagwatwar; Harshal P. & Chow; Diana S. L.
Assignee(s): Board of Regents, The University of Texas System
University of Houston-University Park
Stable parenteral formulations of busulfan safe for parenteral administration are disclosed that exhibit improved bioavailability and optimize high dose busulfan therapy against malignant disease.Patent expiration dates:
- September 30, 2013✓
- March 30, 2014✓✓
- September 30, 2013
Parenteral busulfan for treatment of malignant disease
Patent 5,559,148
Issued: September 24, 1996
Inventor(s): Andersson; Borje S. & Bhagwatwar; Harshal P. & Chow; Diana S.
Assignee(s): Board of Regents, The University of Texas System
University of Houston-University Park
Stable parenteral formulations of busulfan for parenteral administration are disclosed. The improved bioavailability of the parenteral formulations optimizes high dose busulfan therapy against malignant disease and improves the safety of such therapy.Patent expiration dates:
- September 30, 2013✓
- March 30, 2014✓✓
- September 30, 2013
See also...
- Busulfex Consumer Information (Wolters Kluwer)
- Busulfex Consumer Information (Cerner Multum)
- Busulfex Advanced Consumer Information (Micromedex)
- Busulfan Consumer Information (Wolters Kluwer)
- Busulfan Tablet Consumer Information (Wolters Kluwer)
- Busulfan Consumer Information (Cerner Multum)
- Busulfan Intravenous Advanced Consumer Information (Micromedex)
- Busulfan AHFS DI Monographs (ASHP)
MabThera
Mabthera may be available in the countries listed below.
UK matches:
- Mabthera 100mg and 500mg concentrate for solution for infusion (SPC)
Ingredient matches for Mabthera
Rituximab
Rituximab is reported as an ingredient of Mabthera in the following countries:
- Albania
- Argentina
- Aruba
- Australia
- Austria
- Bahrain
- Bangladesh
- Belarus
- Belgium
- Bosnia & Herzegowina
- Brazil
- Chile
- China
- Colombia
- Croatia (Hrvatska)
- Cuba
- Cyprus
- Czech Republic
- Denmark
- Dominican Republic
- Ecuador
- Egypt
- Estonia
- Finland
- France
- Georgia
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Jamaica
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Lebanon
- Lithuania
- Luxembourg
- Macedonia
- Malaysia
- Mexico
- Morocco
- Nepal
- Netherlands
- New Zealand
- Norway
- Oman
- Pakistan
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russian Federation
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Sri Lanka
- Sweden
- Switzerland
- Syria
- Taiwan
- Thailand
- Trinidad & Tobago
- Tunisia
- Turkey
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Venezuela
- Yemen
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Tuesday, August 31, 2010
Helmicide
Helmicide may be available in the countries listed below.
Ingredient matches for Helmicide
Piperazine
Piperazine hexahydrate (a derivative of Piperazine) is reported as an ingredient of Helmicide in the following countries:
- Turkey
International Drug Name Search
Subscribe to:
Posts (Atom)